Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population PK/PD study of vancomycin in preterm neonates
ChiCTR1900027919Phase 4Not yet recruiting
- Sponsor
- Nanjing Maternal and Child Health Hospital
- Start
- Jan 2020
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vancomycin in Infection, sponsored by Nanjing Maternal and Child Health Hospital. Primary endpoints: vancomycin serum concentration, demographics and 4 more. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
vancomycin
03
Conditions
Infection
Beyond the preview
Go deeper on ChiCTR1900027919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027919.